title: Expert attacks decision in US to stop use of bevacizumab for eye condition.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab